← Back to Search

Cannabinoid

Cannabidiol (1 dose) for Diet Modification

Phase < 1
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
non-smoking
non-obese
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Study Summary

Cannabidiol (CBD) is a bioactive cannabinoid compound in marijuana (cannabis sativa), but unlike Δ9 tetrahydrocannabinol (THC), lacks the psychoactivity effect of THC. Available evidence suggests that there are marked therapeutic CBD effects for diverse disease processes including inflammation, cancers, psychosis, and epileptic seizures. The purpose of this study, in both younger and older healthy humans, is to improve our understanding of how CBD might control and regulate blood vessel health as well as cognitive and exercise performance.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Circulating cannabidiol and nitric oxide markers
Vascular function
Secondary outcome measures
Anxiety Questionnaire
Body mass index
Cognitive performance
+9 more

Trial Design

5Treatment groups
Active Control
Placebo Group
Group I: Cannabidiol (1 dose)Active Control1 Intervention
Only cannabidiol supplement.
Group II: Cannabidiol only (2 dose)Active Control1 Intervention
Only cannabidiol supplement.
Group III: Cannabidiol and herbal capsules (2 dose)Active Control1 Intervention
Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.
Group IV: Cannabidiol and herbal capsules (1 dose)Active Control1 Intervention
Cannabidiol supplement with added ginseng, ginkgo biloba, and organic hemp oil.
Group V: PlaceboPlacebo Group1 Intervention
Sugar pill that will have no effect.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,407 Previous Clinical Trials
1,766,525 Total Patients Enrolled
4 Trials studying Diet Modification
461 Patients Enrolled for Diet Modification
Lexaria Bioscoence CorpUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Mar 2025